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ARTICLE
Systemic loss of Sarm1 protects Schwann cells
from chemotoxicity by delaying axon degeneration
Weili Tian1, Tim Czopka 2 & Hernán López-Schier1*
Protecting the nervous system from chronic effects of physical and chemical stress is a
pressing clinical challenge. The obligate pro-degenerative protein Sarm1 is essential for
Wallerian axon degeneration. Thus, blocking Sarm1 function is emerging as a promising
neuroprotective strategy with therapeutic relevance. Yet, the conditions that will most benefit
from inhibiting Sarm1 remain undefined. Here we combine genome engineering, pharma-
cology and high-resolution intravital videmicroscopy in zebrafish to show that genetic
elimination of Sarm1 increases Schwann-cell resistance to toxicity by diverse chemother-
apeutic agents after axonal injury. Synthetic degradation of Sarm1-deficient axons reversed
this effect, suggesting that glioprotection is a non-autonomous effect of delayed axon
degeneration. Moreover, loss of Sarm1 does not affect macrophage recruitment to nerve-
wound microenvironment, injury resolution, or neural-circuit repair. These findings anticipate
that interventions aimed at inhibiting Sarm1 can counter heightened glial vulnerability to
chemical stressors and may be an effective strategy to reduce chronic consequences of
neurotrauma.
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The peripheral nerves that communicate skin, muscle, andsensory organs with the brain must maintain functionalitythroughout life despite frequent stress and trauma1–6. Loss
of integrity of peripheral neurons and associated cells, including
glia, is a common occurrence in severe neurological dysfunctions
that include weakness, pain, and loss of sensation7. Glial loss leads
to nerve demyelination, defasciculation, and neuronal death. Nerve
injury triggers axon fragmentation and degeneration. In turn, this
induces the dedifferentiation of associated glial cells, which
enhances glial role in nerve repair. However, dedifferentiation also
makes glia vulnerable to degeneration after protracted denerva-
tion8–12. Damaged axons undergo Wallerian degeneration13, which
is triggered by the evolutionary ancient pro-degenerative protein
Sarm1 (Sterile Alpha and TIR Motif containing 1)14–17. Sarm1 is a
modular protein that contains two sterile-alpha motifs (SAM), one
mitochondrial association (MT) and one TIR domain14. Nerve
injury activates Sarm1 by TIR dimerization, which is sufficient
to induce axonal degeneration18,19. Mechanistically, Sarm1 acti-
vation results in the loss of nicotinamide adenine dinucleotide
(NAD+) in damaged axons20–22. The TIR domain acts as a
NADase23, explaining why over-expression of the NAD+-syn-
thesizing enzyme NMNAT1 inhibits the degradation of severed
axons by sustaining high levels of NAD+ downstream of Sarm1
(ref. 24). Moreover, the loss of Sarm1 blocks the degeneration of
injured axons, and forced activation of Sarm1 induces axon
destruction in the absence of injury. Therefore, Sarm1 is a hier-
archical regulator of a signaling pathway that is necessary and
sufficient for axonal degradation22. Upon peripheral-nerve injury,
glial Schwann cells acquire a specialized function that promotes the
clearance of axon fragments ahead of axonal re-growth from the
proximal stump25. Expeditious axonal regeneration is important
because sustained Schwann-cell denervation leads to protracted
loss of glial terminal phenotype and eventual death. In turn, glial
loss impairs regenerating nerve myelination and circuit repair,
transforming acute neuropathies into irreversible chronic neuro-
logical dysfunction. Therefore, inhibiting or delaying axon
destruction has been hypothesized as an effective strategy to
counter heightened Schwann-cell vulnerability to additional stres-
sors that include metabolic imbalance and drugs26,27. As a discrete
hierarchical factor that is essential for axon degeneration, Sarm1
is an ideal target for pharmacological interventions18. This
idea has sparked intense efforts to identify specific molecular
inhibitors of axon degeneration for clinical applications28,29.
However, the conditions that would most benefit from inhibiting
Sarm1 systemically are yet to be defined30,31. Here we address
the above issue using the powerful genetics of zebrafish, a small
vertebrate whose nervous system is anatomically simple but
functionally similar to that of mammals32–34. Crucially, the zeb-
rafish larva is ideal to study Schwann-cell biology in the natural
context of the behaving animal35–42. By characterizing loss-of-
function mutations in Sarm1, we provide novel insights into the
cellular basis of axon–glia interactions, and provide data that
encourage the quest to identify and develop Sarm1 inhibitors for
clinical applications.
Results
Identification and mutagenesis of Sarm1 in zebrafish.
The amino-acid sequence of Sarm1 is well conserved across
species15,43. To identify Sarm1 orthologs in zebrafish, we scanned
publicly accessible genomic data (Danio rerio reference genome
assembly version GRCz11) by a BLAST search using the TIR
domain, which is present in all known Sarm1 proteins15,44. This
exploration yielded a single candidate locus in chromosome 15.
No other part of the zebrafish genome appears to harbor Sarm1
paralogs. The genomic structure of the putative zebrafish Sarm1
reminisces that of other species, containing 8 exons that code for
a protein of 713 amino acids, with the typical N-terminal auto-
inhibitory domain, 2 central SAM multimerization domains, and
a C-terminal TIR degeneration domain (Fig. 1a). Similar to
Drosophilla melanogaster, however, D. rerio Sarm1 lacks an
obvious mitochondria-targeting sequence (MT). To test whether
the identified gene produces a protein with the expected func-
tional role, we used CRISPR/Cas9-mediated genome modification
to generate loss-of-function mutations in Sarm1. By targeting
exon 1, we obtained germ-line transmission of two alleles:
sarm1hzm13 and sarm1hzm14 (Supplementary Fig. a, b). The
hzm13 allele introduces an 11-base deletion and T/C mutation,
resulting in a frameshift and premature stop codon. hzm14 is a
7-base deletion and AG/GA mutation that also generates a fra-
meshift and premature stop codon. Analysis of protein extracts
from wild-type embryos by western blot using an antibody
to Sarm1 revealed a single band of approximately 80 kDa, which
agrees with the expected size of the full-length protein (Supple-
mentary Fig. 1c). This band was absent in protein extracts from
homozygous sarm1hzm13 zebrafish embryos. Of note, because this
antibody recognizes an epitope in the C-terminus of Sarm1, it
does not allow to discriminate between the expression of a
truncated protein lacking all the domains with known function,
and the complete absence of Sarm1 induced by nonsense-
mediated mRNA decay. Homozygous sarm1hzm13 mutants dis-
play no overt anatomical defects (Supplementary Fig. 1d, e), are
viable, and develop into fertile adults. Furthermore, a simple assay
for sensorimotor function that consists of eliciting the escape
response after tactile stimuli showed that the displacement dis-
tance and the average acceleration were no different between wild
type and Sarm1 mutants (Supplementary Fig. 1f, g)45.
Functional conservation of Sarm1 in axon degeneration.
Although Sarm1 has already been extensively studied in neurons
of Drosophila and mice, we deemed necessary to assess the
effects of systemic loss of Sarm1 on neuronal and non-neuronal
cells in larval zebrafish. This is because no single study has
addressed Sarm1 function holistically, in a single organism, by
intravital high-resolution microscopy. To this end, we used
several parameters of nervous-system structure and function by
combining sarm1hzm13 with transgenes expressing fluorescent
markers in the sensory neurons of the mechanosensory lateral
line, as well as in their associated Schwann cells46,47. The lateral-
line system is ideal for such in vivo studies under normal and
altered conditions48–51. It combines the organization of a typical
vertebrate sensory system with the amenability for controlled
experimental interventions that include microsurgery, pharma-
cology, and optogenetics41,42,52,53. We found that loss of Sarm1
does not affect the development and structure of the lateral-line
sensory pathway (Supplementary Fig. 1h–n). For a more
detailed analysis, we fluorescently marked mitochondria in
sensory neurons by expressing the mitochondria-targeting
sequence of the cytochrome-C oxidase subunit 8A fused to
mCherry54. We chose to study mitochondria because they are
dynamic organelles that distribute throughout the neuron by
active transport mediated by molecular motors that move along
microtubule tracks. In axons, microtubules are polarized such
that their plus ends are directed toward the axon terminals, in
turn orienting the movement of distinct molecular motors in the
antero- and retrograde directions55. Intra-axonal movement
direction reflects mitochondrial fitness because stressed orga-
nelles are biased in the retrograde direction56,57. Therefore,
axonal mitochondria represent an optimal proxy for neuronal
polarization, intracellular dynamics, and overall health. We
found a qualitatively similar number, density, and distribution
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of mitochondria in the peripheral axons of wild type and Sarm1-
mutant animals. Kymographic analysis revealed a majority of
static large mitochondrial groups, and some smaller fragments
moving substantial distances at constant velocity in the ante-
rograde and retrograde directions (Fig. 1b, c). Importantly,
quantifications showed no significant differences in the number
and spatial distribution of axonal mitochondria (Fig. 1d), or
movement velocity and direction between wild-type and Sarm1-
mutant specimens (Fig. 1e).
Next, we addressed functional conservation of Sarm1 in
zebrafish using a previously established bioassay of neurotrauma
in vivo, which employs laser-mediated severing of individualized
axons using single-neuron fluorescent-protein expression and
high-resolution microscopy41,58. To precisely cut axons, we
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focused an ultraviolet laser beam to a discrete region of the
peripheral nerve. Upon severing, the distal-axon segment quickly
degenerated in wild-type specimens, whereas the proximal
segment that stays associated with the neuronal perikaryon
remained viable (Fig. 1f). Kinetic analysis shows that Sarm1-
deficient severed axons remained stable for over 5 days, whereas
severed wild-type axons degraded within 8 h (Fig. 1g). The
degeneration-resistant phenotype of Sarm1 mutants was elimi-
nated by the transgenic introduction of a fluorescent-tagged full-
length Sarm1 in mutant neurons (Fig. 1h), demonstrating
functional conservation of zebrafish Sarm1.
Loss of Sarm1 does not affect focal damage resolution. Physical
injury often results in inflammatory responses that recruit
immune cells to the wound. After nerve injury, injury-mediated
production of reactive oxygen species (ROS) as well as che-
moattractants produced by Schwann cells recruits inflammatory
cells, including macrophages. Studies ex vivo using mammalian
cultured neurons showed that Sarm1 acts downstream of
mitochondrial ROS generation. Therefore, we decided to test
in vivo if the loss of Sarm1 or the absence of Schwann cells
would affect macrophage recruitment to the site of injury.
To this end, we generated a transgenic line expressing
membrane-targeted EGFP under the control of the macrophage-
specific promoter Mfap4. We combined this line with Tg
[SILL:mCherry] and mutations in Sarm1 or Erbb2. Loss
of Erbb2 in zebrafish impairs Schwann-cell migration along
lateral-line axons and leads to nerve unmyelination and
defasciculation53,59. We injured nerves with a laser and assessed
macrophage behavior at high resolution. We found that the
onset of recruitment and the number of macrophages at the
wound did not differ between wild-type specimens and Sarm1
or Erbb2 mutants (Fig. 2a and Supplementary Movies 1–3).
Macrophages arrived from various locations and moved in a
qualitatively indistinguishable manner along the proximal and
distal part of the axons in wild type and mutant specimens.
Quantitative imaging showed that the retention time of mac-
rophages at the proximal side of the wound was unaltered in
Sarm1 or Erbb2 mutants, although on average retention was
marginally lengthened in the absence of Schwann cells (Fig. 2b).
In wild type, Sarm1, and Erbb2 mutants, macrophages engulfed
debris locally at the injury site, and did not appear to be
involved in the degradation of the distal part of the severed
axons (Supplementary Movies 1–3). We found, however, a sig-
nificant increase in the size of the engulfed debris by macro-
phages in Erbb2-mutant animals (Fig. 2c). These results reveal
that the loss of Sarm1 does not affect focal damage resolution by
macrophages. Also, importantly, they indicate that macrophages
are recruited to the wound independently of the Schwann cells.
We did notice discrete and highly mobile axon fragments that
were not associated with EGFP(+) cells in wild type and Erbb2-
mutant animals, but not in Sarm1-deficient fish.
Synthetic degradation of severed Sarm1-deficient axons.
Calcium (Ca2+) regulation in neurons is critical for homeostasis
because sustained elevation of cytosolic calcium leads to axonal
and neuronal degeneration. Often, this occurs because mito-
chondria release apoptosis-inducing factors and proteases in a
calcium-dependent manner60. Studies of mammalian neurons
in vitro and of zebrafish have shown that neuronal damage
triggers two waves of elevation of axoplasmic calcium (Ca2+)21,52.
The first occurs nearly immediately after injury and decays
rapidly, whereas the second has slower onset and decay. Loss of
Sarm1 prevents Ca2+ elevation in severed axons21. We sought to
further test the functional conservation of Sarm1 in zebrafish
in vivo by monitoring Ca2+ dynamics in lateralis sensory axons at
Fig. 1 Functional conservation of Sarm1 in zebrafish. a Structure Sarm1 indicating alignment of the Sarm1 functional domains from different species (not at
scale). b Confocal image of axonal mitochondria marked with mito-mCherry in wild type and Sarm1−/−. Red arrows point to prominent mitochondrial
groups in axons. c Upper panels, kymographs from videomicroscopic recording of axonal mitochondria in wild type (H) (left panel) and Sarm1−/− (I) (right
panel). Lower panels show color-coded traces of moving mitochondria in anterograde (green) and retrograde (red) directions, taken from the kymographs
shown in the upper panels. d Density of mitochondria in 5 dpf wild type and Sarm1−/−, error bar= SEM. n.s.= not significant, p value from Student’s t-test,
n= 25 (WT), n= 19 (Sarm1−/−). e Mobility of the mitochondria in 5 dpf wild type and Sarm1−/−. Circles show the anterograde and triangles the
retrograde movement of the mitochondria. p value from one-way ANOVA, wild type n= 26, Sarm1−/− n= 26. f Time-lapse images of axonal degeneration
of GFP-labeled lateralis sensory neuron in wild type (left) and Sarm1−/− larvae (right). hpi= hour post-injury, scale bar= 50 μm, white asterisk indicates
the regrowing axons from the proximal stump. g Quantification of the time from axon transection to fragmentation in wild type (n= 13) and Sarm1−/− (n=
13). h shows a recue experiment in which the expression of a functional Sarm1 in sensory neurons of Sarm1-mutant fish (right-hand side panels) suffices to
degrade severed axons, similarly to wild-type fish (left-hand side panels). Middle panels show non-degradable Sarm1-deficient severed axons.
Fig. 2 Sarm1 deficiency does not affect damage resolution. a Quantification of the number of macrophages recruited to the injury site and adjacent axon
segments. b Quantification of the time macrophages interact with axon segments. c Quantification of the size of debris within macrophages. One-way
ANOVA was conducted firstly, then p values for T-test in between two individual group.
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high resolution before and after injury. We measured Ca2+
dynamics in toto at high resolution before and after axon
injury using the genetically encoded ultrasensitive Ca2+ sensor
GCaMP7a to find that intact wild type and Sarm1-mutant axons
show undetectable levels of axoplasmic fluorescence above
background (Fig. 3a). Upon severing, fluorescent signal in wild-
type axons distal segments increased immediately and subse-
quently decayed with a near constant slope, whereas fluorescence
remained nearly undetectable in Sarm1-deficient distal-axon
segments (Fig. 3b). Next, we examined the Ca2+ levels in mito-
chondria and the endoplasmic reticulum (ER) using genetically
encoded vital sensors, respectively, Mito-RGECO and ER-
GCaMP3 (Fig. 3c–f). We selected these organelles because Ca2+
release from the axonal ER activates the mitochondrial perme-
ability transition pore to trigger axonal degeneration61,62. We
found that both mitochondrial and reticular Ca2+ levels increased
equally after axon severing in severed wild type and Sarm1−/−
axons. These results reveal that loss of Sarm1 attenuates calcium
influx to the axoplasm, but not Ca2+ uptake in mitochondria or
the ER.
Because the second Ca2+ wave is responsible for the activation
of the serine–threonine protease Calpain, which in turn facilitates
axonal fragmentation by cleaving microtubules and neurofila-
ments63, we decided to monitor Ca2+ levels in lateralis sensory
axons 2, 4, 8, and 12 h post-injury (hpi). In severed wild-type
axons, the second wave of axoplasmic Ca2+ starts 4 hpi in
coincidence with axon fragmentation, and remains elevated in
axonal debris up until 8 hpi (Fig. 4a). Note that the temporal
resolution of these images does not allow the resolution of
degeneration before axonal regeneration. By contrast, the second
wave of axoplasmic Ca2+ does not occur in Sarm1-mutant axons
(Fig. 4b). Thus, we hypothesized that forcing a sustained elevation
of axoplasmic Ca2+ will be sufficient to trigger the degradation of
severed Sarm1-deficient axons. To test this prediction, we
transgenically expressed the rat transient receptor potential
cation channel subfamily V member 1 (TRPV1) fused to tagRFP
in lateralis afferent neurons of Sarm1-mutant zebrafish. Expres-
sion of mCherry alone in neurons served as control. TRPV1 is
non-selective cation channel that exhibits a high divalent
selectivity, and whose activation produces an influx of Ca2+ into
Fig. 3 Loss of Sarm1 attenuates Ca2+ influx to the axoplasm of severed axons, but not Ca2+ uptake in mitochondria or the ER. a Confocal image of a
single lateralis sensory axon expressing the green-fluorescent calcium sensor GCaMP7a in wild type (left column) and Sarm1−/− fish (right column).
Rows show that the same samples before laser-mediated transection (top), immediately after transection (middle), and 60 s after transection (bottom). In
a, c, and e, white arrowheads indicate the position of the axon, specifically when signal-to-background is low. Scale bar 20 μm. b shows quantification of the
first wave of axoplasmic calcium. Data are shown as mean ± SEM; p from one-way ANOVA, wild type n= 16, Sarm1−/− 16. c shows a confocal image of
lateralis sensory axons expressing the red-fluorescent calcium sensor RGECO in wild type (left column) and Sarm1−/− fish (right column). Rows show
that same samples before laser-mediated transection (top), immediately after transection (middle), and 60 s after transection (bottom). d Quantification
mitochondrial calcium influx shows the strong and nearly identical elevation and decay in wild type and Sarm1−/− immediately after the cuts. Data are
shown as mean ± SEM; p from one-way ANOVA, wild type n= 16, Sarm1−/− 16. e shows a confocal image of lateralis sensory axons expressing the green-
fluorescent calcium sensor CCaMP3 targeted to the endoplasmic reticulum (ER) in wild type (left column) and Sarm1−/− fish (right column). Rows show
that same samples before laser-mediated transection (top), immediately after transection (middle), and 60 s after transection (bottom). f Quantification
ER calcium influx shows strong and statistically equal elevation and decay in wild type and Sarm1−/− after the cuts. Data are shown as mean ± SEM;
p from one-way ANOVA, wild type n= 16, Sarm1−/− 16.
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cells64. Rat TRPV1 is activated by temperatures above 43 °C or by
the vanilloid capsaicin. Importantly, this TRPV1 is inactive at the
temperature used to maintain zebrafish (28 °C), and zebrafish
TRPV1 orthologs are insensitive to capsaicin65. Therefore, rat
TRPV1 expressed in zebrafish offers a tunable tool to elevate
axoplasmic Ca2+ with excellent temporal resolution. We severed
TRPV1-expressing and mCherry-expressing lateralis axons, and
2 h later a vehicle solution or vehicle+ capsaicin were added in
the water holding the fish (Supplementary Fig. 2a, b). Samples
were inspected 90 min later. Severed Sarm1-deficient axons not
expressing TRPV1 did not fragment in the presence of capsaicin,
or TRPV1-expressing axons bathed in ethanol solution. As
hypothesized, we found that Sarm1-deficient TRPV1-expressing
axon segments readily degraded in the presence of capsaicin
(Supplementary Fig. 2c–f). These results demonstrate for the first
time in vivo that elevation of axoplasmic Ca2+ downstream of
Sarm1 is sufficient to trigger axon degradation.
Schwann cells are not essential to maintain Sarm1−/− axons.
The Schwann cells support, fasciculate, and myelinate sensory
axons in vertebrates66. We reasoned that delayed axon degen-
eration by loss of Sarm1 might impact the interaction between
axons and Schwann cells. To assess this interaction in vivo, we
combined the sarm1hzm13 allele with the triple transgenic line Tg
[gSAGFF202A; UAS-GFP; SILL:mCherry] to highlight the
Schwann cells with green fluorescence and the lateralis afferent
neurons with red fluorescence53,67. Using high-resolution intra-
vital microscopy, we ascertained that Schwann cells develop
normally and fasciculate sensory axons in Sarm1-deficient zeb-
rafish (Fig. 5a). Upon severing, wild-type axons were quickly
cleared by the Schwann cells through engulfment of axonal
fragments and intracellular degradation of debris (Fig. 5b, Sup-
plementary Movie 4). Thus, we asked if Schwann cells are
necessary for the maintenance of severed Sarm1-deficient axons
by generating a double mutant zebrafish line concurrently defi-
cient for Erbb2 and Sarm1. In Erbb2-deficient specimens, the
distal portion of the severed axons fragmented and were cleared
(Fig. 6a–d) but with a significant delay compared to wild-type
specimens (Fig. 6a–d). By contrast, in Erbb2/Sarm1 double
mutants, severed axons did not fragment or degrade, identically
to fish lacking only Sarm1 (Fig. 6c, d). Thus, axon maintenance in
Sarm1 mutants occurs independently of the Schwann cells.
When an injury generates a gap in the glia, wound-adjacent
Schwann cells actively move and extend cellular projections
resembling filopodia to quickly reconstitute a continuous glial
scaffold53. Although continuous glia are not necessary for the
Fig. 4 Sarm1 is necessary for late onset axoplasmic Ca2+ influx in
severed axons. a Confocal image of a lateralis sensory axons expressing
the mCherry (red) and green-fluorescent calcium sensor GCaMP7a (green)
in wild-type fish. Rows show same axons 2, 4, 8, and 12 h after transection
(hours post-injury= hpi). b Confocal image of lateralis sensory axons
expressing the mCherry (red) and green-fluorescent calcium sensor
GCaMP7a (green) in Sarm1−/− fish. Scale bar 20 μm.
Fig. 5 Schwann cells develop normally in Sarm1-deficient zebrafish. a Confocal images of a double-transgenic 5dpf larva showing Schwann cells marked
by expression of GFP (green) under the control of the Tg[gSAGFF202A] Gal4 driver, and lateralis afferent neurons marked by expression of mCherry
under the control of the SILL enhancer (red). Wild type (top), Sarm1 mutants (bottom). Scale bar 20 μm. b Images show the indicated time points after
axon transection (hours post-injury= hpi) from a videomicroscopic recording of Schwann cells (green) and their interaction with axons (red) in wild type
and Sarm1−/−. White arrowheads indicate Schwann cells engulfing axonal debris in the wild type. A white arrow indicates degradation-resistant axon
segment in Sarm1−/−. Please note that the proximal axon stump in Sarm1−/− is not visible in these images because it is outside the focal plane.
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re-growth of the proximal axon stump, it prevents regenerating
growth cones from straying, in turn facilitating end-organ de
novo innervation and circuit reconstitution39,41. Thus, we
decided to interrogate Schwann-cell behavior immediately after
axon severing and during axon regeneration combining Tg
[gSAGFF202A;UAS-GFP; SILL:mCherry] double transgene with
the Sarm1 mutation. As expected, we found that in wild-type
animals, the Schwann cells adjacent to the wound quickly
extended filopodia to close the gap in the glial scaffold ahead of
axonal regeneration (Supplementary Movie 5). Regrowing fibers
then followed these subcellular glial bridges to reconstitute the
nerve, suffering mild defasciculation restricted to a small area
within the injury (Fig. 6e, Supplementary Fig. 3). In stark
contrast, injury-adjacent Schwann cells did not migrate or
produce filopodia-like projections in Sarm1 mutants (Supple-
mentary Movie 6). Nonetheless, regenerating axons eventually
negotiated the persistent larger gap to grow along the distal glial
scaffold. However, the reforming nerves presented more pro-
nounced local defasciculation (Fig. 6f, Supplementary Fig. 4).
Loss of Sarm1 does not alter Schwann-cell phenotype. Dener-
vated Schwann cells undergo partial dedifferentiation from
myelinating to a progenitor-like state as revealed by the loss of
expression of terminal-phenotype markers, including myelin and
myelin-associated proteins25,68,69. The loss of terminal phenotype
promotes Schwann-cell proliferation and migration, which
enhances their regenerative function70. We hypothesized that
because Schwann-cell denervation does not occur in Sarm1
mutants, distal Schwann cells may not dedifferentiate. This would
explain their lack of phagocytic and protrusive activities after
axon transection. Following this rationale, we immunostained
samples with an antibody to Claudin-k, which localizes to the
junctions between mature Schwann cells and is downregulated in
denervated glia41,71. In wild-type specimens, Claudin-k remained
strongly expressed along the entire length of the lateralis afferent
nerve up to 6 h after nerve injury (hpi), suggesting that distal
Schwann cells remain mature during distal-axon fragmentation
(Fig. 7a, b). Beginning at 10 hpi, however, distal Schwann cells
had markedly less Claudin-k than proximal cells. Finally, 24 hpi
Fig. 6 Schwann cells are not essential for the maintenance of Sarm1-deficient sensory axons. a–c Images of mCherry-expressing (red) transected axons
in wild type (a), Erbb2−/− mutants (b), and Sarm1−/−; ErBb2−/− double mutants (c). Scale bar 100 μm. d Quantification of transected axon
fragmentation in Erbb2−/− and Sarm1−/−; ErBb2−/−. Error bar= SEM, p value from one-way ANOVA test, n= 15 (each group). e Image of from
Supplementary Movie 1, showing the discrete local defasciculation of regenerated the sensory fiber (red) and the bridging of the glial gap by Schwann cells
(green) in a wild-type specimen. f Equivalent experiment, taken from Supplementary Movie 2, showing a more pronounced local defasciculation of the
regenerated the sensory fiber (red) in a Sarm1-mutant specimen. Note that the bridging of the glial gap does not occur.
COMMUNICATIONS BIOLOGY | https://doi.org/10.1038/s42003-020-0776-9 ARTICLE
COMMUNICATIONS BIOLOGY |            (2020) 3:49 | https://doi.org/10.1038/s42003-020-0776-9 | www.nature.com/commsbio 7
Claudin-k was conspicuously absent from distal Schwann cells
even after axons regeneration had commenced. By contrast,
Claudin-k remained strongly expressed after axon severing in
Sarm1-mutant animals during the same period, with no apparent
difference between Schwann cells located at either side of the
wound (Fig. 7a–c). Next, we assessed myelination using the 6D2
monoclonal antibody, which recognizes a carbohydrate epitope in
the piscine P0-like myelin glycoproteins IP1 and IP2 (refs. 72,73).
As with Claudin-k, 6D2 labeling faded in Schwann cells distal to
the injury in wild-type specimens (Fig. 8a). Yet, 6D2 labeling
remained unchanged in Sarm1 mutants (Fig. 8b). We obtained
congruent results when addressing myelination directly in living
specimens by using a transgenic line expressing membrane-
targeted EGFP under the control of the myelin-binding protein
(Mbp:EGFP-CAAX, green) (Fig. 8c, d)74. Interestingly, forced
degradation of Sarm1-deficient severed axons expressing the rat
TRPV1 channel after capsaicin treatment induced associated
Schwann cells to dedifferentiate (Supplementary Fig. 2g). Toge-
ther, these results indicate that Sarm1-deficient sensory axons are
maintained independently of Schwann-cell support, and that the
clearance of the severed axons is not necessary for regenerating
axon growth, pathfinding, myelination, and re-innervation of
sensory organs. In addition, they reveal that Schwann cells distal
to the injury do not dedifferentiate in Sarm1-mutant specimens.
Loss of Sarm1 protects Schwann cells from chemical toxins.
Many chemotherapeutic agents invariably cause peripheral neu-
rotoxicity, leading to permanent neuronal dysfunction75–79.
Under conditions of denervation, Schwann cells become strongly
susceptible to chemotoxicity80. We wondered if the protracted
maintenance of severed axons in Sarm1 mutants may suppress
glial vulnerability. To test this idea, we treated wild type and
Sarm1-mutant zebrafish with several chemical compounds that
are under clinical trials or used as first-line treatment for com-
mon cancers in humans. First, we used 10-hydroxycamptothecin
(10-HCT), which is extremely toxic to denervated glia81, and
counted Schwann cells using the fluorescence transgenic marker
Tg[gSAGFF202A; UAS:EGFP], which is ideal for this experiment
because the intensity of green fluorescence does not vary in
denervated Schwann cells and, therefore, is independent of the
maturity of these glia41. We confirmed that 10-HCT does not
affect the Schwann cells associated to viable axon (Fig. 9a, b).
However, it significantly reduced the number of Schwann cells in
10-HCT-treated wild-type animals after axon severing. By con-
trast, the number of distal Schwann cells was only marginally
affected in Sarm1-mutant specimens (Fig. 9b). Platinum-based,
taxanes and some alkaloids are effective chemotherapeutic agents
used as standards-of-care for various human malignancies,
despite their severe neuropathic effects that include glial
destruction82. To address their effect on Schwann cell, we treated
wild type or Sarm1 mutant zebrafish with cisplatin, oxaliplatin,
paclitaxel, docetaxel, and vincristine. We found that upon nerve
transection, all these drugs invariably killed injury-distal Schwann
cells in wild-type specimens but not in Sarm1 mutants (Fig. 9c).
Importantly, none of these drugs affected Schwann cells asso-
ciated with intact axons, suggesting that axons protect Schwann
cells from chemical stress. To confirm this prediction, we forced
the degradation of severed axons in Sarm1-deficient zebrafish
treated with 10-HCT or vincristine. To this end, we repeated the
used of capsaicin to activate rat TRPV1 expressed in a sub-set of
lateralis neurons in homozygous mutant fish, in which Sarm1 is
absent from every cell, including Schwann cells. This experiment
revealed that Schwann cells lacking Sarm1 again become vul-
nerable to chemotoxicity once severed axons were synthetically
eliminated (Fig. 9d), confirming that Sarm1-mediated gliopro-
tection is non-autonomous and depends upon the presence of
non-degradable axons.
Discussion
The sensory neurons that innervate skin, sensory receptors, joints,
and muscle communicate peripheral information to the brain,
enabling animals to perform the essential activities of daily life.
Using zebrafish and a battery of tests that include subcellular
structural characterization of sensory neurons and associated
Schwann cells, neuronal function, and behavioral assays, we offer
a comprehensive and integrated analysis of neuronal and glial
response to injury, as well as on the consequences of blocking
axon degeneration systemically. It has been well established that
Fig. 7 Schwann cells maintain terminal phenotype in Sarm1-deficient zebrafish. a–c Schematic model of the confocal imaging locations on severed axons
(a). Confocal images of wild type (b) and Sarm1−/− (c) specimens in 6, 10, and 24hpi. hpi hour post-injury. The specimens were the Tg[gSAGFF202A;
UAS:EGFP; SILL:mCherry] lines and were stained with Claudin-k (magenta) antibody. Scale bar 50 μm.
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the absence of Sarm1 in Drosophila and the mouse prevents the
degradation of damaged axons15,83. Although we were not pre-
dicting any differences for the Sarm1 ortholog in zebrafish,
assaying functional conservation in our experimental neuronal
pathway is not dispensable because some neurotraumatic condi-
tions lead to neuronal loss in the absence of Sarm1. Loss of Sarm1
improves functional recovery after traumatic brain injury in mice,
and inhibits vincristine-mediated neurotoxicity84,85. Sarm1-
deficient mice are viable19,86. We found that chronic and sys-
temic loss of Sarm1 is compatible with zebrafish viability and
sensorineural function, and demonstrate that the long-term
maintenance of non-degradable axon fragments has no detri-
mental effect on the repair of a sensory circuit. Furthermore,
regenerating axons fasciculate and myelinate normally, indicating
that they do not compete with non-degradable axons segments
for exiting glia. Therefore, we conclude that the axonal destructive
and nerve reconstructive processes occur in parallel. In addition,
these data suggest that a competitive balance between axon
degradation and regeneration does not appear to have shaped the
evolution of Sarm1 and, by extension, Wallerian degeneration.
Fig. 8 The clearance of the severed axons is not essential for neuronal-circuit repair. a, b Confocal images of wild type (a) and Sarm1−/− (b) specimens
expressing EGFP in sensory neurons of the lateral line (green) and stained with the monoclonal antibody 6D2. Stainings were performed at indicated time
points after axons severing (hpi). The arrows point to the cutting sites. Scale bar is 50 μm. c Live imaging of the Tg[Mbp-EGFP; SILL:mCherry] after severing.
The arrows indicated the fragmented axons and the arrowheads the fragmented myelin. Scale bar 20 μm. d Live imaging of the Sarm1−/− in Tg[Mbp-EGFP;
SILL:mCherry] after severing. Arrows indicate regrowing axons, and arrowheads indicate the juxtaposition between the regrowing axons. Scale bar 20 μm.
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Focusing on Schwann cells, we show that glial cells adjacent to
nerve injury in Sarm1 mutants behave dramatically different than
those of wild-type specimens. Specifically, Schwann cells in Sarm1
mutants do not migrate or extend projections to bridge the gap in
the glial scaffold, indicating that these cells do not directly sense
missing intercellular contacts or glial discontinuity. Instead, our
findings suggest alternative scenarios. One is that the degradation of
axons releases signals that induce Schwann cell to change behavior.
In mice, for example, nerve damage promotes mesenchymal
behavior of Schwann cells surrounding the wound via TGF-beta
signaling, which drives collective Schwann-cell migration across the
wound87. Although we did not observe Schwann-cell migration,
signals derived from injured axons may promote wound-adjacent
Schwann cells to extend projections to 88 bridge the gap in a similar
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manner. Interestingly, we observed that filopodia-like structures
emerged from Schwann cells at both sides of the injury in wild-type
animals, suggesting that repair-inducing signals are likely diffusible,
affecting glial cells independently of their association with axons. It
remains to be determined if the source of such signals is the
damaged axons, the denervated Schwann cells, or other cells in the
wound microenvironment.
Upon nerve injury, activated macrophages rapidly accumulate
around the wound and contribute to Wallerian degeneration and
to axonal regeneration. Specifically, classical pro-inflammatory
M1-type phagocytic macrophages remove axonal and myelin
debris, whereas anti-inflammatory M2-type macrophages mod-
ulate Schwann-cell activity and promote axon regeneration89.
Immediately after nerve injury, Schwann cells release chemokines
that attract or retain macrophages at the wound before axon
fragmentation. Importantly, pharmacological activation of mac-
rophage recruitment to the wound microenvironment enhances
axon regeneration, whereas decrease of macrophage infiltration
inhibits axon regeneration. ROS are conserved early wound sig-
nals across species. Injury-mediated ROS production recruits
inflammatory cells, including macrophages. Primary sources of
ROS after nerve damage are the mitochondria and cellular
NADPH oxidases. Studies in ex vivo-cultured neurons indicate
that Sarm1 acts downstream of mitochondrial ROS generation.
Also, previous studies have characterized Wallerian axon
degeneration and regeneration in Erbb2-mutant specimens, but
did not address effects on the wound microenvironment and the
behavior of macrophages90,91. Accordingly, tested in vivo if the
loss of Sarm1 as well as the absence of Schwann cells would affect
macrophage recruitment, to find that the onset of recruitment,
the retention time and number of macrophages at the wound did
not differ between wild-type specimens and Sarm1 or Erbb2
mutants. Also, as in wild-type specimens, macrophages in Sarm1
and Erbb2 mutants engulfed debris locally, which were larger
within macrophages in Ebbr2 mutants. Thus, the loss of Sarm1
does not affect focal damage resolution by macrophages, which
are recruited and activated independently of the Schwann cells.
The above findings suggest that activated phagocytic cells other
than macrophages and Schwann cells, possibly neutrophils92,
engulf and clear distal-axon fragments after damage, and that this
process does not occur in Sarm1-deficient animals.
In conclusion, current mechanistic details about Sarm1 func-
tion derived from independent observations that had been extra-
polated from a wide variety of experimental systems. This has
made it difficult to synthesize findings and reconcile some con-
flicting observations. Here, we have exploited a powerful in vivo
genetic system to comprehensively study the consequence of
systemic loss of Sarm1 from the subcellular to the organismal
level in a single vertebrate system. By generating zebrafish car-
rying loss-of-function mutations in Sarm1, we confirmed and
deepen previous findings from Drosophila, the mouse, and cul-
tured cells. Several novel insights derive from the work presented
here. First, that loss of Sarm1 is well tolerated by the animal.
Second, that neuronal-circuit repair is not contingent upon rapid
clearance of damaged axons. Third, that Schwann cells are not
necessary for maintenance of severed axons in vivo. Fourth, that
after the axotomy Schwann cells distal to the cut site do not
dedifferentiate in Sarm1 mutants in vivo. Fifth, that the pro-
tracted maintenance of transected axons dramatically improves
Schwann-cell tolerance to chemotoxicity after nerve injury after
neurotrauma. This scenario is likely to occur in the clinical setting
because nerve trauma is an inescapable consequence of surgical
interventions, chronic metabolic dysfunction including diabetes,
and pharmacological treatments such as antibiotics and anæ-
sthesia that increase cellular stress82. Therefore, these findings are
of obvious pathophysiological significance. Crucially, these data
lend strong support to the idea that direct interventions to sys-
temically inhibit axon degradation are promising strategies to
reduce chronic consequences of neurotrauma. Because TIR
domain dimerization is necessary and sufficient to degrade NAD
+, it renders Sarm1 amenable to inhibition by small molecules, as
it has been demonstrated for the TIR domain of TLR2 (ref. 93).
Our findings encourage the development of Sarm1 inhibitors for
therapeutic applications18,29.
Methods
Zebrafish strains and husbandry. Zebrafish (D. rerio) were maintained in a
centralized facility in accordance to guidelines by the Ethical Committee of Animal
Experimentation of the Helmholtz Zentrum München, the German Animal Wel-
fare act Tierschutzgesetz §11, Abs. 1, Nr. 1, Haltungserlaubnis, to European Union
animal welfare, and to protocols number Gz.:55.2-1-54-2532-202-2014 and
Gz.:55.2-2532.Vet_02-17-187 from the “Regierung von Oberbayern”, Germany.
The transgenic lines Tg[UAS:EGFP], Tg[HGn39D] and Tg[SILL:mCherry]67, Tg
[gSAGFF202A]41, Tg[UAS:GCaMP7a]94, Tg[mbpa:tgRFP-CAAX]tum102Tg (also
known as Tg[MBP:tgRFP])95 and Erbb2 mutants41,59 have been previously pub-
lished. The Tg[Sarm1−/−] was generated by CRISPR/Cas9-mediated mutagenesis.
Sarm1 mutagenesis. We used CRISPR/Cas9-mediated genome modification to
generate mutations in exon 1 of Sarm1. Cas9 mRNA and sgRNAs were co-injected
into one-cell stage embryos. Cas9 mRNA was generated in vitro from PmeI-
linearized CAS9 vector (pMLM3613) using the AmbionTM mMESSAGE mMA-
CHINE T7 Kit. The mRNA was purified with the RNA easy kit (Qiagen). To
generate the sgRNAs, the target exon was sequenced and the sequence information
was used to design oligonucleotides for the sgRNA guide vector (pDR274) using
the on-line tool “ZiFiT Targeter software package” (http://zifit.partners.org/)96. The
sgRNA sequence for exon 1 of Sarm1 is 5′-GGGACTTGGAAGAGACCCGC-3′.
The annealed oligonucleotide was cloned into the BsaI-digested pDR274 vector
using T4 ligase (NEB M0202). Resulting clones were sequenced to verify correct-
ness, and then linearized with DraI. The purified linearized DNA fragment was
employed to generate the sgRNA using the T7 MEGAscript kit (AmbionTM). By
out-crossing adult fish resulting from injection, we obtained germ-line transmis-
sion of two independent alleles: sarm1hzm13 and sarm1hzm14. For genotyping
mutant carriers, we used the primers: Forward: 5′-GATTTGCCGTTATCT
CTCCA-3′, Reverse: 5′-TCAAGCAGTTTGGCAGACTC-3′.
DNA constructs. The DNA constructs SILL:mCherry, SILL:Gal4 (ref. 67), UAS:
Synapsin1-GFP53, and mbp:EGFP-CAAX have been previously described. The
vectors pMLM3613 (42251) and pDR272 (42250) were purchased from Addgene.
The plasmids UAS:TRPV1-tagRFP, the coding sequence of rat TRPV1 containing
the E600K mutation fused to tagRFP, was synthesized by Genecat and the
expression construct was generated using Tol2 kit. The constructs SILL:mito-
mCherry, SILL:Sarm1-v2a-mCherry, SILL:Kaede, SILL:mitoRGECO, and SILL:
erGCaMP3 were generated using Tol2 kit. Mitochondria in lateralis neurons were
marked by expressing the mitochondria-targeting sequence from the cytochrome-C
Fig. 9 Loss of Sarm1 protects Schwann cells from chemical toxins. a Confocal images showing Schwann cells (green) and lateralis sensory axons (red)
in a control specimen (in which axons were not transected), in a specimen 48 h after axon transection, and in specimens treated with 10-HCT (10-
hydroxycamptothecin). Left column is wild type and right column shows Sarm1−/−. In all cases, the concentration of 10-HCT in water was 40 μm.
Scale bar 100 μm. b Quantification of the Schwann cells from a. Data are shown as mean ± SEM. **p < 0.01, two-way ANOVA, n= 8 (each group), followed
by T-test for two individual group. c Quantification of Schwann cells of WT, WT severed, Sarm1−/− and Sarm1−/− severed with the treatment of the
indicated chemical compounds for 48 h. Concentrations: Paclitaxel 40 μm, Docetaxel 0.1 μm, Oxaliplatin 500 μm, Cisplatin 50 μm, Vincristine 50 μm. Data
are shown as mean ± SEM. *p < 0.05; **p < 0.01, three-way ANOVA, n= 8 (each group), followed by T-test for two individual group. d Quantification of
Schwann cells after axon severing, in specimens treated with 10-HCT or Vincristine. The left bar group is wild type. The right bar group is Sarm1−/−, and
Sarm1−/− with synthetically eliminated axon segments. Two-way ANOVA, followed by T-test for two individual groups.
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oxidase subunit 8A fused to mCherry. The plasmids containing mito-RGECO and
er-GCaMP3 (ref. 97) were a gift of D.W. Raible (University of Washington).
Antibodies and immunostaining. Whole-mount immunostaining was performed
as following. First, samples of zebrafish embryos or larvae were fixed by immersion
in ice-cold 4% paraformaldehyde diluted into phosphate-buffered saline buffer
containing 0.2% Tween-20 (PBST), and incubated overnight at 4 °C. Then, the
samples were washed at room temperature (RT) with PBST three times, 10 min per
wash, and subsequently blocked in 10% bovine serum albumin (BSA), also at RT
for 1 h. Next, the samples were incubated in primary antibodies at 4 °C overnight.
Next, the samples were washed in PBST for 2 h, changing to fresh buffer every
30 min. Finally, they were incubated with secondary antibodies at 4 °C overnight.
Primary antibodies and concentrations: mouse anti-Acetylated tubulin, 1:1000
(Sigma T7251); rat anti-Claudin-k, 1:500 (gift from T. Becker, University of
Edinburgh, UK)71; mouse 6D2, 1:5 (gift from Dr. G. Jeserich, University of
Osnabrück, Germany)73. Secondary antibodies used were at the following con-
centrations: donkey anti-Mouse Alexa Fluor® 555, 1:200, Abcam ab150106; donkey
anti-Rat IgG H&L (Alexa Fluor® 647) pre-adsorbed, 1:200, Abcam ab150155).
Samples were washed in PBST for 30 min and mounted in Vectashield 1 day before
microscopic examination. Imaging of fixed samples was done with a laser-scanning
confocal microscope (LSM 510, Carl Zeiss).
Intravital microscopy. For videomicroscopy, larvae were anesthetized with MS-
222 (0.013% M/V) in Danieau’s and mounted in 0.8% low melting-point agarose
on 35 mm glass-bottom Petri dishes. Samples were gently pressed against the glass
using a hair-loop glued to the tip of a glass pipette, as previously described. The
agarose dome was immersed in Danieau’s with MS-222. Images of cells were
acquired using a spinning-disc microscope with a ×40 air objective at 28.5 °C58. Z-
stacks were set to 0.8–1.2 µm intervals. Time intervals were 10 min or 15 min per
stack. The resulting raw data were processed, assembled, and analyzed with ImageJ.
Western blot assay. Wild type and mutant larvae were anesthetized and killed 5
days-post-fertilization. Samples were homogenized in ice-cold RIPA buffer (with
protease inhibitor cocktail from Roche (Cat.04693159001). After homogenization, the
samples were incubated on ice for 30min for further lysis. The resulting lysate was
centrifuged at 1200 r.p.m. at 4 °C, and the supernatant was taken for the BCA assay.
The supernatant was diluted in loading buffer and boiled at 99 °C for 5min. Next, the
samples were run in SDS-PAGE and transferred onto a PVDF membrane. After
blocking the membrane in 5% skimmed milk (diluted in PBST) for 1 h, the membrane
was incubated with the primary antibody (rabbit anti-Sarm1, 1:500, ANASPEC 55381;
Mouse anti-β-Tubulin, 1:2000, Sigma T5168) at 4 °C overnight. The next day, the
membrane was washed and incubated with HRP-labeled secondary antibody (Per-
oxidase-Affini Pure Goat Anti-Mouse IgG (H+ L), 1:10000, Jackson Immuno
Research 115035003; Peroxidase-Affini Pure Goat Anti-Rabbit IgG (H+ L), 1:10000,
Jackson ImmunoResearch 115035144) for 1 h. Images were acquired by developing the
membrane with ECL (Pierce™ ECLWestern Blotting Substrate, Thermo Fisher, 32109).
Laser microsurgery. To mark lateralis sensory neurons individually, DNA of the
SILL:mCherry construct was injected into eggs of Tg[HGn39D], Tg[HGn39D;
Sarm1−/−], Tg[SILL:mCherry; gSAGFF202A; UAS:EGFP] or Tg[SILL:mCherry;
gSAGFF202A; UAS:EGFP; Sarm1−/−] zebrafish. Resulting larvae were selected
according to red fluorescence in lateralis neurons. Selected samples were mounted
into agarose as described above, and their peripheral axons were targeted an
ultraviolet laser (350 nm) using the iLasPulse system (Roper Scientific AS, Evry,
France), as described previously. The laser beam was delivered using a ×63 water-
immersion objective50,53,58. The laser pulses were calibrated and applied to the
target area until a clear gap in the axons was visible. The samples were observed
again 1 hpi to confirm complete axon transection.
Quantification of mitochondrial density and motility. To analyze mitochondria
in sensory axons, we generated kymographs of mito-mCherry fluorescent spots
using the Multi-Kymograph tool of the Fiji software (http://fiji.sc). The movement
of mitochondria was determined by the slope of the lines drawn over time, and the
direction of movement was determined by the moving mitochondria crossing the
time line (vertical) in the kymographs. The data were analyzed with Python scripts
and the Graphpad Prism software.
Calcium imaging. For calcium imaging in lateralis neurons, Tg[SILL:Gal4; UAS:
GCaMP7a] double-transgenic larvae were anesthetized and mounted in 0.8% low
melting-point agarose on a 35 mm glass-bottom Petri dish. Imaging was acquired
through a ×63 water-immersion objective with an exposure time of 400 ms. Laser-
mediated axon transection was done after the fourth imaging of the time series.
Next, live videomicroscopy was done for 2 min at a frame rate of 400 ms at 28.5 °C.
The raw data were analyzed with ImageJ. To quantify the calcium signal, the
images were processed to ImageJ. The region of interest (ROI) was selected and
measured the value with time point. GCaMP or RGECO intensity changes were
calculated as follows: ΔF/F0= (F–F0)/F0, where F0 is the value of the fluorescent
signal before axons were transected, and F is the value of the fluorescent signal with
time point after axon severing97.
Chemogenetics. For chemogenetic experiments, we co-injected the SILL:Gal4 with
UAS:mCherry or UAS:ratTRPV1-tagRFP into the Tg[UAS:GCaMP7a] or Tg
[HGn39D; Sarm1−/−]. The positive larva with SILL:Gal4; UAS:ratTRPV1-tagRFP;
UAS:GCaMP7a expression was used to activate TRPV1 channels in zebrafish by
incubation in 5 μM capsaicin (Sigma, M2028) and subsequent live imaging for 1 h
of the mounted and anesthetized embryo. Images were acquired through a ×63
water-immersion objective with an exposure time of 400 ms. For experiments with
the Sarm1 mutant larvae, the HGn39D with SILL:mCherry or ratTRPV1-tagRFP
positive animals were laser axotomized. The larvae were treated with 10 μM cap-
saicin or ethanol (1:1000, v/v) 2 h after transection. At 1.5 h after capsaicin treat-
ment, images were taken by spinning-disc microscopy.
Behavioral assays. For the touch-mediated escape response, 2 dpf embryos were
gently dechorionated and kept in Danieau’s solution at 28 °C for at least 1 h.
Embryos were place into a flat uncovered Petri dish containing Danieau’s and were
recorded with a high-speed camera (NX4 series, Imaging solution, GmbH). Video
recording was launched and a randomly chosen embryo was touched with a blunt
glass needle until it evoked a reaction. Recordings were done under white-light
illumination over 150 s at a rate of 200 frames per second (fps). The swimming
trajectories were obtained with 3D Particle Tracker plugin, ImageJ software. The
further quantification and statistics were using Python.
Statistics and reproducibility. The Student’s t-test (two tailed), ANOVA test,
T-test (Tukey test), and Wilcoxon rank sum test were applied using Python scripts.
Error bars in all figures are standard errors of the mean (SEM).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data supporting the findings of this study are available within the paper and its
supplementary information. Reagents generated during the study are available from the
corresponding author on reasonable request.
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